| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Beryl Koener, Stéphanie Goursaud, Morgane Van De Stadt, André-Guilhem Calas, Anne P Jeanjean, Jean-Marie Maloteaux, Emmanuel Herman. Pharmacological blockade of dopamine D2 receptors by aripiprazole is not associated with striatal sensitization. Naunyn-Schmiedeberg's archives of pharmacology. vol 383. issue 1. 2011-07-15. PMID:21061116. |
however, at variance with haloperidol, repeated administrations of aripiprazole(3 weeks) at the doses of 10 and 30 mg/kg did not induce any up-regulation or hyperfunctionality of the dopamine d₂ receptors in the striatum. |
2011-07-15 |
2023-08-12 |
rat |
| Hwan Soo Jang, Ji Young Kim, Sang Heon Kim, Maan-Gee Le. Role of dopamine receptors on electroencephalographic changes produced by repetitive apomorphine treatments in rats. The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology. vol 13. issue 3. 2011-07-14. PMID:19885030. |
to study the role of dopamine receptors in eeg changes, we examined the effect of apomorphine, the dopamine d1 receptor antagonist, sch-23390, and the d2 receptor antagonist, haloperidol, on eeg in rats. |
2011-07-14 |
2023-08-12 |
rat |
| S K Kulkarni, C Deshpande, A Dhi. Ascorbic Acid inhibits development of tolerance and dependence to opiates in mice: possible glutamatergic or dopaminergic modulation. Indian journal of pharmaceutical sciences. vol 70. issue 1. 2011-07-14. PMID:20390081. |
ascorbic acid, haloperidol (dopamine antagonist) or mk 801 (nmda receptor antagonist) was administered daily for 9 d before challenging the animals with morphine. |
2011-07-14 |
2023-08-12 |
mouse |
| Hong-zhu Li, Jin Guo, Jun Gao, Li-ping Han, Chun-ming Jiang, Hong-xia Li, Shu-zhi Bai, Wei-hua Zhang, Guang-wei Li, Li-na Wang, Hong Li, Ya-jun Zhao, Yan Lin, Ye Tian, Guang-dong Yang, Rui Wang, Ling-yun Wu, Bao-feng Yang, Chang-qing X. Role of dopamine D2 receptors in ischemia/reperfusion induced apoptosis of cultured neonatal rat cardiomyocytes. Journal of biomedical science. vol 18. 2011-06-10. PMID:21324201. |
here we investigated the effects of both dopamine d2 receptors agonist (bromocriptine) and antagonist (haloperidol) on apoptosis of cultured neonatal rat ventricular myocytes induced by ischemia/reperfusion injury. |
2011-06-10 |
2023-08-12 |
rat |
| D A Moshkov, M B Abramova, V S Shubina, V P Lavrovskaya, L L Pavlik, E I Lezhne. Effect of dopamine on viability of BHK-21 cells. Bulletin of experimental biology and medicine. vol 149. issue 3. 2011-05-26. PMID:21246101. |
preliminary blockade of dopamine receptors with haloperidol, inessential for cell survival and morphology, does not prevent the destructive effect of dopamine on the cells. |
2011-05-26 |
2023-08-12 |
Not clear |
| K Riedinger, A Kulak, W J Schmidt, A von Ameln-Mayerhofe. The role of NMDA and AMPA/Kainate receptors in the consolidation of catalepsy sensitization. Behavioural brain research. vol 218. issue 1. 2011-05-25. PMID:21130808. |
daily injection of the dopamine d(2) receptor antagonist haloperidol is associated with the development of catalepsy sensitization in rats, which leads to a day to day increase of rigor and akinesia. |
2011-05-25 |
2023-08-12 |
rat |
| E L Dovedova, D N Voronkov, R M Khudoerko. Effects of short-term exposure to haloperidol and reserpine on dopamine turnover in nigrostriatal system in rat brain. Bulletin of experimental biology and medicine. vol 150. issue 2. 2011-05-20. PMID:21240369. |
effects of short-term exposure to haloperidol and reserpine on dopamine turnover in nigrostriatal system in rat brain. |
2011-05-20 |
2023-08-12 |
rat |
| E L Dovedova, D N Voronkov, R M Khudoerko. Effects of short-term exposure to haloperidol and reserpine on dopamine turnover in nigrostriatal system in rat brain. Bulletin of experimental biology and medicine. vol 150. issue 2. 2011-05-20. PMID:21240369. |
spectrophotometric methods were employed to determine activity of dopamine metabolism enzymes, tyrosine hydroxylase and monoamine oxidase b, in nigrostriatal structures of the brain in wistar rats after short-term (60 min) haloperidol or reserpine treatment. |
2011-05-20 |
2023-08-12 |
rat |
| E L Dovedova, D N Voronkov, R M Khudoerko. Effects of short-term exposure to haloperidol and reserpine on dopamine turnover in nigrostriatal system in rat brain. Bulletin of experimental biology and medicine. vol 150. issue 2. 2011-05-20. PMID:21240369. |
we hypothesized the presence of a phase of dopamine metabolism activation, aimed at maintenance of dopamine transmission and nervous system adaptation at early terms after reserpine and haloperidol administration. |
2011-05-20 |
2023-08-12 |
rat |
| J E de Leeuw van Weenen, H E Auvinen, E T Parlevliet, C P Coomans, J P Schröder-van der Elst, O C Meijer, H Pij. Blocking dopamine D2 receptors by haloperidol curtails the beneficial impact of calorie restriction on the metabolic phenotype of high-fat diet induced obese mice. Journal of neuroendocrinology. vol 23. issue 2. 2011-05-05. PMID:21062378. |
blocking dopamine d2 receptors by haloperidol curtails the beneficial impact of calorie restriction on the metabolic phenotype of high-fat diet induced obese mice. |
2011-05-05 |
2023-08-12 |
mouse |
| Stephen M Phipps, Veronika Butterwec. A new digitized method of the compulsive gnawing test revealed dopaminergic activity of salvinorin A in vivo. Planta medica. vol 76. issue 13. 2011-03-14. PMID:20217638. |
), while the dopamine antagonist haloperidol did successfully block (0.06 mg/kg, i.p.) |
2011-03-14 |
2023-08-12 |
mouse |
| S Cechova, A M Elsobky, B J Vento. A1 receptors self-regulate adenosine release in the striatum: evidence of autoreceptor characteristics. Neuroscience. vol 171. issue 4. 2011-03-10. PMID:20933584. |
the decrease in adenosine is not a downstream effect of lowered dopamine release, as decreasing dopamine synthesis and release with α-methyl-p-tyrosine or increasing release with haloperidol had no effect on adenosine release. |
2011-03-10 |
2023-08-12 |
Not clear |
| Fei Li, L Phillip Wang, Xiaoming Shen, Joe Z Tsie. Balanced dopamine is critical for pattern completion during associative memory recall. PloS one. vol 5. issue 10. 2011-03-07. PMID:21060884. |
this form of memory recall deficit in the dopamine transporter heterozygous knockout mice can be reversed by a low dose of the dopamine antagonist haloperidol, further confirming that the inability to retrieve memory patterns is a result of dopamine imbalance. |
2011-03-07 |
2023-08-12 |
mouse |
| Marianne Benoit-Marand, Bérangère Ballion, Emiliana Borrelli, Thomas Boraud, Francois Gono. Inhibition of dopamine uptake by D2 antagonists: an in vivo study. Journal of neurochemistry. vol 116. issue 3. 2011-02-17. PMID:21128941. |
however, prolonged stimulation boosted dopamine uptake and this effect was not observed after haloperidol treatment or in mice lacking d(2) receptors. |
2011-02-17 |
2023-08-12 |
mouse |
| Juliano C Capra, Mauricio P Cunha, Daniele G Machado, Andrea D E Zomkowski, Beatriz G Mendes, Adair Roberto S Santos, Moacir G Pizzolatti, Ana Lúcia S Rodrigue. Antidepressant-like effect of scopoletin, a coumarin isolated from Polygala sabulosa (Polygalaceae) in mice: evidence for the involvement of monoaminergic systems. European journal of pharmacology. vol 643. issue 2-3. 2010-12-28. PMID:20599906. |
the pretreatment of mice with ketanserin (5mg/kg, i.p., a preferential 5-ht(2a) receptor antagonist), prazosin (1mg/kg, i.p., an alpha(1)-adrenoceptor antagonist), yohimbine (1mg/kg, i.p., an alpha(2)-adrenoceptor antagonist), haloperidol (0.2mg/kg, i.p., a dopaminergic receptor antagonist), sch23390 (0.05 mg/kg, s.c., a dopamine d(1) receptor antagonist) or sulpiride (50mg/kg, i.p., a dopamine d(2) receptor antagonist), but not way100635 (0.1mg/kg, s.c., a selective 5-ht(1a) receptor antagonist) prevented the antidepressant-like effect of scopoletin (10mg/kg, p.o.) |
2010-12-28 |
2023-08-12 |
mouse |
| T J Banasikowski, A Bespalov, K Drescher, B Behl, L Unger, A Haupt, H Schoemaker, J P Sullivan, G Gross, R J Beninge. Double dissociation of the effects of haloperidol and the dopamine D3 receptor antagonist ABT-127 on acquisition vs. expression of cocaine-conditioned activity in rats. The Journal of pharmacology and experimental therapeutics. vol 335. issue 2. 2010-11-23. PMID:20724485. |
double dissociation of the effects of haloperidol and the dopamine d3 receptor antagonist abt-127 on acquisition vs. expression of cocaine-conditioned activity in rats. |
2010-11-23 |
2023-08-12 |
rat |
| Cristiano R Jesse, Ethel A Wilhelm, Cristiani F Bortolatto, Cristina W Nogueir. Evidence for the involvement of the noradrenergic system, dopaminergic and imidazoline receptors in the antidepressant-like effect of tramadol in mice. Pharmacology, biochemistry, and behavior. vol 95. issue 3. 2010-11-01. PMID:20184917. |
in the fst was blocked with yohimbine (1mg/kg, i.p., an alpha(2)-adrenoceptor antagonist), alpha-methyl-para-tyrosine methyl ester (ampt, 100mg/kg, i.p., an inhibitor of tyrosine hydroxylase), efaroxan (1mg/kg, i.p., an imidazoline i(1)/alpha(2)-adrenoceptor antagonist), idazoxan (0.06mg/kg, i.p., an imidazoline i(2)/alpha(2)-adrenoceptor antagonist), antazoline (5mg/kg, i.p., a ligand with high affinity for the i(2) receptor), haloperidol (0.2mg/kg, i.p., a non selective dopamine receptor antagonist), sch23390 (0.05mg/kg, subcutaneously, s.c., a dopamine d(1) receptor antagonist), sulpiride (50mg/kg, i.p., a dopamine d(2) and d(3) receptor antagonist) but was not reversed by prazosin (1mg/kg, intraperitoneally, i.p., an alpha(1)-adrenoceptor antagonist) and caffeine (3mg/kg, i.p., a nonselective adenosine receptor antagonist). |
2010-11-01 |
2023-08-12 |
mouse |
| Takaaki Matsuo, Yasuhiko Izumi, Seiko Wakita, Toshiaki Kume, Yuki Takada-Takatori, Hideyuki Sawada, Akinori Akaik. Haloperidol, spiperone, pimozide and aripiprazole reduce intracellular dopamine content in PC12 cells and rat mesencephalic cultures: Implication of inhibition of vesicular transport. European journal of pharmacology. vol 640. issue 1-3. 2010-10-04. PMID:20460122. |
haloperidol, spiperone, pimozide and aripiprazole reduce intracellular dopamine content in pc12 cells and rat mesencephalic cultures: implication of inhibition of vesicular transport. |
2010-10-04 |
2023-08-12 |
rat |
| Takaaki Matsuo, Yasuhiko Izumi, Seiko Wakita, Toshiaki Kume, Yuki Takada-Takatori, Hideyuki Sawada, Akinori Akaik. Haloperidol, spiperone, pimozide and aripiprazole reduce intracellular dopamine content in PC12 cells and rat mesencephalic cultures: Implication of inhibition of vesicular transport. European journal of pharmacology. vol 640. issue 1-3. 2010-10-04. PMID:20460122. |
pretreatment with haloperidol, spiperone, pimozide, aripiprazole and risperidone markedly inhibited high potassium-evoked dopamine release. |
2010-10-04 |
2023-08-12 |
rat |
| Takaaki Matsuo, Yasuhiko Izumi, Seiko Wakita, Toshiaki Kume, Yuki Takada-Takatori, Hideyuki Sawada, Akinori Akaik. Haloperidol, spiperone, pimozide and aripiprazole reduce intracellular dopamine content in PC12 cells and rat mesencephalic cultures: Implication of inhibition of vesicular transport. European journal of pharmacology. vol 640. issue 1-3. 2010-10-04. PMID:20460122. |
haloperidol, spiperone, pimozide, chlorpromazine, aripiprazole and olanzapine evoked dopamine release, while sulpiride and risperidone had no effect. |
2010-10-04 |
2023-08-12 |
rat |